Clinical Laserthermia Systems AB
CLS | ST
Overview
Corporate Details
- ISIN(s):
- SE0022049912 (+3 more)
- LEI:
- 549300TH4O6D9205O691
- Country:
- Sweden
- Address:
- Scheelevägen 2, 223 81 Lund
- Website:
- https://clinicallaser.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Clinical Laserthermia Systems (CLS) is a medical technology company that develops and markets advanced systems for minimally invasive, high-precision laser ablation of diseased tissue. Its flagship product, the TRANBERG® Thermal Therapy System, is an integrated platform designed for image-guided treatments with real-time monitoring and control. The company's technology is primarily applied in urology for the focal therapy of localized prostate cancer and in neurosurgery for treating brain tumors and epileptogenic foci. CLS's solutions aim to improve patient outcomes by targeting lesions precisely, sparing healthy tissue, and reducing side effects, enabling faster patient recovery. The company also advances immune-stimulating ablation techniques to enhance anti-cancer responses.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Clinical Laserthermia Systems AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Clinical Laserthermia Systems AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Clinical Laserthermia Systems AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-23 | Hans von Celsing | Other | Sell | 4,000 | 15,200.00 SEK |
